Market News
Latest news from Stock markets.
DMRC Deadline: Rosen Law Firm Urges Digimarc Corporation (NASDAQ: DMRC) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025. Digimarc is a digital watermarking technology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Digimarc Corporati.
...keep reeding on businesswire.com
Meta reportedly hires four more researchers from OpenAI
Looks like Meta isn't done poaching talent from OpenAI.
...keep reeding on techcrunch.com
Cloudflare stock price forecast: eying ATH after flipping key resistance
Cloudflare stock price has gone parabolic and crossed an important resistance level as demand for its services and its market share soared. NET jumped to a high of $195, its highest level since November 2021, and 410% above its lowest point in 2022, giving it a market cap of over $60 billion.
...keep reeding on invezz.com
GoviEx Uranium begins 2025 drilling at Muntanga uranium project - ICYMI
GoviEx Uranium Inc (TSX-V:GXU, OTCQB:GVXXF) earlier this week began its 2025 field season at the Muntanga uranium project in Zambia. CEO Daniel Major joined Proactive to discuss the program, which is moving beyond resource drilling to broader exploration that could significantly enhance the project's economics.
...keep reeding on proactiveinvestors.com
DNUT Deadline: DNUT Investors with Losses in Excess of $100K Have Opportunity to Lead Krispy Kreme, Inc. Securities Fraud Lawsuit
NEW YORK , June 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Krispy Kreme, Inc. (NASDAQ: DNUT) between February 25, 2025 and May 7, 2025, both dates inclusive (the "Class Period"), of the important July 15, 2025 lead plaintiff deadline. So what: If you purchased Krispy Kreme securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
Oil News: Can Crude Oil Hold 200-Day MA Despite OPEC Production Surge?
Oil posts worst week since March 2023, down 12% on Israel-Iran ceasefire. OPEC+ production hike adds pressure but Friday bounce suggests oversold conditions.
...keep reeding on fxempire.com
Rosen Law Firm Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
NEW YORK , June 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Eagle Bancorp, Inc. (NASDAQ: EGBN) resulting from allegations that Eagle Bancorp may have issued materially misleading business information to the investing public. So What: If you purchased Eagle Bancorp securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
Rosen Law Firm Encourages GoHealth, Inc. Investors to Inquire About Securities Class Action Investigation - GOCO
NEW YORK , June 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
Down 48%, Should You Buy the Dip on Rigetti Computing?
Quantum computing specialist Rigetti Computing (RGTI -0.18%) soared sky-high at the end of 2024, but gave back a lot of those gains in the first half of 2025. On June 25, the stock is trading 48% below January's peak prices.
...keep reeding on fool.com
Meta hires four more OpenAI researchers, The Information reports
Meta Platforms is hiring four more OpenAI artificial intelligence researchers, The Information reported on Saturday.
...keep reeding on reuters.com
Tech Corner: TSLA
After its Robotaxi unveiling, Tesla (TSLA) heads to the Tech Corner! George Tsilis dives into the EV maker's business which is more than just cars: energy storage, solar power, robotics and more.
...keep reeding on youtube.com
HIVE Digital Technologies eyes $100M in AI revenue as it expands in Paraguay - ICYMI
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) executive chairman Frank Holmes talked with Proactive about the company's strategic growth through its expansion into Paraguay and the scaling of its high-performance computing (HPC) capabilities. Holmes outlined how HIVE increased its electricity capacity from 100MW to over 300MW in Paraguay by acquiring Bitfarms' operation.
...keep reeding on proactiveinvestors.com
Lindsay Corporation: Q3 Earnings Indicate Strength But Limited Upside
Lindsay Corporation (LNN) has shown strong recent performance, but currently trades near fair value with limited near-term upside catalysts. Q3 earnings were robust, driven by international irrigation sales and improved operating income, while the balance sheet remains healthy with strong cash flow. Dividend growth is steady but modest, with a low payout ratio and 22 years of increases, though future raises could be more substantial.
...keep reeding on seekingalpha.com
ELV Deadline: ELV Investors with Losses in Excess of $100K Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit
NEW YORK , June 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period"), of the important July 11, 2025 lead plaintiff deadline. So what: If you purchased Elevance Health common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
DMRC Deadline: DMRC Investors with Losses in Excess of $100K Have Opportunity to Lead Digimarc Corporation Securities Fraud Lawsuit
NEW YORK , June 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the "Class Period"), of the important July 8, 2025 lead plaintiff deadline. So what: If you purchased Digimarc securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
Cyngn Stock: Should You Buy The Nvidia Hype?
Cyngn (NASDAQ:CYN) stock has surged over 300% in just two trading days after AI chip titan Nvidia named the company in a blog post as one of a select group of robotics innovators using its Isaac robotics platform to build autonomous industrial vehicles. Cyngn specializes in autonomous vehicle technology tailored for industrial and logistics applications.
...keep reeding on forbes.com
LPRO Deadline: Rosen Law Firm Urges Open Lending Corporation (NASDAQ: LPRO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Open Lending Corporation (NASDAQ: LPRO) securities between February 24, 2022 and March 31, 2025. Open Lending is a provider of loan services to auto lenders. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the All.
...keep reeding on businesswire.com
First Phosphate advances Bégin-Lamarche project with bulk sample - ICYMI
First Phosphate Corp. (CSE:PHOS, OTCQB:FRSPF) CEO John Passalacqua talked with Proactive about the company's recent metallurgical testing progress and next steps toward a feasibility study for its Bégin-Lamarche project in Quebec. The company has collected a 5,000-kilogram bulk sample to refine its phosphate separation process and further validate its earlier pilot results, which had already achieved nearly 90% phosphate recovery.
...keep reeding on proactiveinvestors.com
JPMorgan: Robust Preferred Dividends Thanks To An Exceptional Performance
JPMorgan's Q1 results demonstrate robust profitability, with preferred dividends covered even under severe earnings stress, supporting the safety of preferred shares. I favor JPMorgan's preferred shares for their risk/reward profile, especially given their seniority over common equity and the bank's strong financials. While yields on JPMorgan preferreds aren't the highest, the bank's stability justifies a slightly lower return compared to peers like Wells Fargo.
...keep reeding on seekingalpha.com
BITF Deadline: BITF Investors with Losses in Excess of $100K Have Opportunity to Lead Bitfarms Ltd. Securities Fraud Lawsuit
NEW YORK , June 28, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitfarms Ltd. (NASDAQ: BITF) between March 21, 2023 and December 9, 2024, both dates inclusive (the "Class Period"), of the important July 8, 2025 lead plaintiff deadline.
...keep reeding on prnewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DV
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the “Class Period”), of the important July 21, 2025 lead plaintiff deadline.
...keep reeding on globenewswire.com
HPE and Juniper Networks Reach Settlement With U.S. Department of Justice
HOUSTON & SUNNYVALE, Calif.--(BUSINESS WIRE)--Hewlett Packard Enterprise (NYSE: HPE) and Juniper Networks, Inc. (NYSE: JNPR) today announced they have reached an agreement with the U.S. Department of Justice (“DOJ”) that, subject to court approval, resolves the DOJ's lawsuit challenging HPE's acquisition of Juniper and clears the way for the transaction to close. “Our agreement with the DOJ paves the way to close HPE's acquisition of Juniper Networks and preserves the intended benefits of this.
...keep reeding on businesswire.com
Warren Buffett is giving away $6 billion in Berkshire shares
Warren Buffett has just dropped his latest charitable donation — $6 billion worth of Berkshire Hathaway shares. The Berkshire chairman said he would donate around 12.4 million Class B shares to five charities.
...keep reeding on businessinsider.com
These ETFs Pay More Than Treasuries
The 10-year U.S. Treasury yield has a pretty decent yield that's just shy of 4.3% at the time of this writing.
...keep reeding on 247wallst.com
China EV Giant's Stock Up 40%, Tesla Down 20%
It says a great deal about the EV industry that China's BYD shares are up 40% this year, while America's Tesla (NASDAQ: TSLA) is off 20%.
...keep reeding on 247wallst.com
Apple: The Mag 7's Dead Money Stock or AI Cash Cow in the Making?
As of the June 26 close, Apple NASDAQ: AAPL is the worst-performing stock in 2025 among the vaunted Magnificent Seven. The formerly most valuable stock in the world has provided a total return of approximately -20%.
...keep reeding on marketbeat.com
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines
Next phase builds on 34+ years of serving the needs of US patients and healthcare providers COLUMBUS, Ohio , June 28, 2025 /PRNewswire/ -- In its ongoing mission to help meet America's growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities. This new phase of investment -- America Leans on Hikma: Quality Medicines Manufactured in the USA – will further expand Hikma's well-established domestic capabilities to develop, produce and deliver a broad range of medicines needed by the US healthcare system to treat patients nationwide.
...keep reeding on prnewswire.com
Meta Platforms (Nasdaq: META) CEO Mark Zuckerberg Goes All-In On AI
Meta (NASDAQ: META) is aggressively ramping up AI efforts by investing $15 billion in Scale AI and personally recruiting a top-tier “super intelligence” team, signaling a strategic push to catch up in foundational model development.
...keep reeding on 247wallst.com
STAG Industrial: A Bird-In-Hand Dividend Opportunity
STAG Industrial's reliable monthly dividends and resilient cash flow provide peace of mind, especially when growth stocks falter. Current market disfavor for REITs creates an attractive entry point, with STAG offering a compelling 4%+ yield and undervalued FFO multiple. STAG's growth runway remains long, driven by ongoing warehouse expansion, accretive acquisitions, and strong demand from e-commerce and nearshoring trends.
...keep reeding on seekingalpha.com
FTRE Investors Have Opportunity to Lead Fortrea Holdings, Inc. Securities Fraud Lawsuit
NEW YORK , June 28, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Fortrea Holdings, Inc. (NASDAQ: FTRE) securities between July 3, 2023 and February 28, 2025, both dates inclusive (the "Class Period"), of the important August 1, 2025 lead plaintiff deadline. So what: If you purchased Fortrea securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
My Oil And Gas Income Is Glorious And Strong
I love to collect income from the essentials in our economy, and we all rely heavily on oil and gas. We look at two excellent ways to collect oil-price connected income. Your retirement needs cash flow; let's find excellent sources together.
...keep reeding on seekingalpha.com
Baselode Energy CEO details Geiger Energy merger and uranium exploration vision - ICYMI
Baselode Energy Corp (TSX-V:FIND, OTCQB:BSENF) CEO James Sykes talked with Proactive about the strategic merger with Forum Energy Metals Corp to create Geiger Energy, a new uranium exploration company with substantial assets in Canada's premier uranium basins. Forum's CEO Rebecca Hunter also joined the conversation to outline Geiger's operational roadmap and drilling plans.
...keep reeding on proactiveinvestors.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Apple Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AAPL
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Apple Inc. (NASDAQ: AAPL) between June 10, 2024 and June 9, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 19, 2025.
...keep reeding on globenewswire.com
I Gambled on Margin with MSTY – Will I Regret This Risky Move?
Gambling on a margin is a terrible idea, even if you've been on a bit of a lucky streak with a knack for spotting winners of late.
...keep reeding on 247wallst.com
Warning To REIT Investors: Rate Cuts Are Coming Soon
REITs have suffered a three-year-long bear market. They could offer significant upside in a future recovery. I think the next leg of the REIT rally is very close. I explain why.
...keep reeding on seekingalpha.com
The Best AI Agent Stocks to Buy in 2025
Agentic AI refers to models trained to use tools, access data, and take real-world actions—potentially redefining software through personalization and automation.
...keep reeding on 247wallst.com
3 No-Brainer Warren Buffett Stocks to Buy Right Now
There's no need to go on about the success that Berkshire Hathway has seen under the stewardship of Warren Buffett and his team. They have outperformed the market and made billions in the process.
...keep reeding on fool.com
WST Deadline: Rosen Law Firm Urges West Pharmaceutical Services, Inc. (NYSE: WST) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025. West describes itself as a “medical supplies company specializing in packaging components, containment solutions, and delivery systems for injectable drugs.” For more information, submit a form, email attorney Phillip Kim, o.
...keep reeding on businesswire.com
3 Absurdly Cheap Stocks Ready for a Breakout
The stock market is trading at record highs once again, but not all stocks have participated in the big rally off the April lows, and those are the stocks I am constantly looking for. In a market that appears overvalued, cheap stocks are harder to come by.
...keep reeding on fool.com
Nvidia's climb toward $4 trillion, Tesla's sales decline
Nvidia's record-breaking week has pushed the company close to a $4 trillion market cap. We look at the stock's massive turnaround from the beginning of the year and what could drive it higher.
...keep reeding on youtube.com
Marijuana Market Watch: Stocks to Track as the Industry Expands in 2025
The U.S. cannabis industry continues to expand as legalization momentum builds. In 2025, total market revenue is projected to exceed $45 billion. Additionally, over two-thirds of Americans now live in a state where cannabis is legal. Many operators are scaling rapidly to meet this demand. Meanwhile, new legislation could further loosen restrictions at the federal level. These shifts present unique opportunities for investors focused on growth sectors. However, volatility remains high. Therefore, traders must approach cannabis stocks with discipline. Technical analysis plays a vital role here. Watching for volume spikes, trend confirmations, and breakout patterns can help pinpoint setups. Still, no setup is complete without a risk plan. Stop-loss levels should be pre-determined. Proper position sizing is also key. These tools allow traders to control downside while remaining flexible. As we begin the week, several top marijuana stocks appear promising based on their chart setups and recent price behavior.
...keep reeding on marijuanastocks.com
Is Nvidia An Underrated AI Stock?
Nvidia (NVDA 1.74%) already dominates AI, but Wall Street might still be underestimating its software moat, data center growth, and edge AI ambitions, unless rising rivals or overvaluation spoil the party. In this video, I break down why Nvidia might still have room to surprise in the next five years.
...keep reeding on fool.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
...keep reeding on globenewswire.com
Pomerantz Law Firm Announces the Filing of a Class Action Against Civitas Resources, Inc. and Certain Officers – CIVI
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv- 03791, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Civitas securities between February 27, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
...keep reeding on globenewswire.com
Pomerantz Law Firm Announces the Filing of a Class Action Against Bitfarms Ltd. and Certain Officers – BITF
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bitfarms Ltd. ("Bitfarms" or the "Company") (NASDAQ: BITF) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-02630, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Bitfarms securities between March 21, 2023 and December 9, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
...keep reeding on globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caleres, Inc. - CAL
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Caleres, Inc. (“Caleres” or the “Company”) (NYSE: CAL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
...keep reeding on globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in DoubleVerify Holdings, Inc.of Class Action Lawsuit and Upcoming Deadlines - DV
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against DoubleVerify Holdings, Inc. (“DoubleVerify” or the “Company”)(NYSE: DV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
...keep reeding on globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming Deadlines - OGN
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
...keep reeding on globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KBR, Inc. - KBR
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
...keep reeding on globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gilead Sciences, Inc. (“Gilead” or the “Company”) (NASDAQ: GILD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
...keep reeding on globenewswire.com